Overview

Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal

Status:
Completed
Trial end date:
2019-08-30
Target enrollment:
Participant gender:
Summary
This is a prospective randomized double-blind controlled trial assessing the benefits of intramuscular ketorolac before or immediately after office ureteral stent removal.
Phase:
Phase 2
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Treatments:
Ketorolac
Ketorolac Tromethamine